title: [A Case of Cecal Cancer with Multiple Cutaneous Metastases].
abstract: We encountered a case of cutaneous metastases from colorectal carcinoma. A 63-year-old woman underwent laparoscopic-assisted ileocecal resection for cecal cancer. Computed tomography (CT) showed multiple liver metastases. The tumor was diagnosed as a well-differentiated adenocarcinoma and was staged as pSE, pN1, sH2, ly1, v1, CP0cM0, fStage Ⅳ. She was treated with 33 courses of the 5-fluorouracil, Leucovorin, and irinotecan (FOLFIRI) regimen and 15 courses of the 5-fluorouracil, Leucovorin, and oxaliplatin (mFOLFOX6) plus bevacizumab regimen. Thirty-four months after resection, multiple cutaneous tumors were noted, predominantly on the lower abdomen, and we resected 2 of them. Histologically, the specimens were diagnosed as well-differentiated adenocarcinoma, which was similar to that of cecal carcinoma. After 1 course of regorafenib, she died 3 years after the primary surgical resection.
authors.affiliation: Dept. of Surgery, Sumitomo Hospital.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Komoto
authors.forename: Ryota
authors.initials: R
authors.lastname: Tanaka
authors.forename: Naoki
authors.initials: N
authors.lastname: Kametani
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Kato
authors.forename: Shigehito
authors.initials: S
authors.lastname: Yamagata
authors.forename: Kazunori
authors.initials: K
authors.lastname: Nakazawa
authors.forename: Isao
authors.initials: I
authors.lastname: Kanehara
authors.forename: Eiji
authors.initials: E
authors.lastname: Ako
authors.forename: Nobuya
authors.initials: N
authors.lastname: Yamada
authors.forename: Shigehiko
authors.initials: S
authors.lastname: Nishimura
authors.forename: Shigeki
authors.initials: S
authors.lastname: Fujita
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Taenaka
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002430:Cecal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000556:secondary